15.44
Vtv Therapeutics Inc Aktie (VTVT) Neueste Nachrichten
vTv Therapeutics Inc. stock retracement – recovery analysisPortfolio Risk Summary & High Yield Equity Trading Tips - Newser
Will Volume Confirm Reversal in vTv Therapeutics Inc.2025 Breakouts & Breakdowns & Free Technical Pattern Based Buy Signals - sundaytimes.kr
Should you hold or exit vTv Therapeutics Inc. nowAnalyst Upgrade & Weekly High Return Forecasts - Newser
Custom strategy builders for tracking vTv Therapeutics Inc.July 2025 Chart Watch & Momentum Based Trading Ideas - Newser
vTv Therapeutics Inc. Stock Support and Resistance Levels You Should KnowMarket Growth Report & Technical Analysis for Trade Confirmation - Newser
vTv Therapeutics (NASDAQ:VTVT) Earns Buy Rating from HC Wainwright - Defense World
How Resilient Is vTv Therapeutics Inc. Stock During Economic DownturnsWeekly Stock Recap & Growth Focused Entry Point Reports - Newser
vTv Therapeutics Inc. Hits Oversold Level on RSI IndicatorJuly 2025 Summary & Smart Swing Trading Techniques - newsyoung.net
Buy Signal for vTv Therapeutics Inc. Stock Key Technical Indicators to WatchRate Cut & Risk Adjusted Buy/Sell Alerts - Newser
Smart tools for monitoring vTv Therapeutics Inc.’s price actionWeekly Profit Summary & Free Weekly Watchlist of Top Performers - Newser
What machine learning models say about vTv Therapeutics Inc.2025 Historical Comparison & Reliable Price Breakout Signals - Newser
What earnings revisions data tells us about vTv Therapeutics Inc.Market Activity Summary & Low Risk High Win Rate Stock Picks - Newser
VTv Therapeutics Q2 Financial Results: $6M LossNews and Statistics - IndexBox
Short Interest Drops in vTv Therapeutics Inc. After RallyJuly 2025 Pullbacks & Capital Protection Trade Alerts - beatles.ru
VTv Therapeutics: Q2 Earnings Snapshot - Huron Daily Tribune
vTv Therapeutics Reports Q2 2025 Financials, Advances Cadisegliatin Trials, and Appoints New CFO - AInvest
Is vTv Therapeutics Inc. trending in predictive chart models [Quarterly Profit Review]Short-Term Trading Alerts - Newser
How to monitor vTv Therapeutics Inc. with trend dashboardsFree Alpha Driven Watchlist With Alerts - Newser
What’s next for vTv Therapeutics Inc. stock priceEquity Signal Recap With Long-Term Summary - Newser
vTv Therapeutics and the Potential of Cadisegliatin in Transforming Type 1 Diabetes Management - AInvest
vTv Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update | VTVT Stock News - GuruFocus
vTv Therapeutics Reports Q2 2025 Results, Phase 3 CATT1 Trial Begins - AInvest
vTv Therapeutics Reports First Participant Randomized in Phase 3 CATT1 Trial for Cadisegliatin and Expands Intellectual Property Portfolio - Quiver Quantitative
vTv Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update - GlobeNewswire
Novel Oral Diabetes Drug Enters Phase 3 Trial: vTv's Potential First-in-Class Treatment Advances - Stock Titan
Is vTv Therapeutics Inc. trending in predictive chart modelsAI Screener Based Stock Summary Report - Newser
Using fundamentals and technicals on vTv Therapeutics Inc.ROI Prediction from Long-Term Holding Plans - Newser
What makes vTv Therapeutics Inc. stock price move sharplySummary of Long-Term Buy Zone Stocks - Newser
vTv Therapeutics VTVT Q2 2025 Earnings Preview Upside Potential on Strategic Partnerships - AInvest
Using data models to predict vTv Therapeutics Inc. stock movementChart Confirmation Setup with ROI Signals - Newser
vTv Therapeutics Announces USPTO Allowance of Patent Covering Cadisegliatin | VTVT Stock News - GuruFocus
vTv Therapeutics Receives Notice of Allowance for Cadisegliatin Patent, Strengthening Protection for Type 1 Diabetes Treatment - Quiver Quantitative
vTv Therapeutics Announces USPTO Allowance of Patent Covering Cadisegliatin - GlobeNewswire
vTv Secures 20-Year Patent Protection for First-in-Class Type 1 Diabetes Drug Cadisegliatin - Stock Titan
Does vTv Therapeutics Inc. fit your quant trading modelFree Growth Focused Entry Plan Suggestions - Newser
Relative strength of vTv Therapeutics Inc. in sector analysisSwing Watchlist With Tight Stop Placement - Newser
What MACD and RSI say about vTv Therapeutics Inc.Short-Term Trade Setup with Forecast Insight - Newser
Why vTv Therapeutics Inc. stock attracts strong analyst attentionAI Triggered Buy Zone Forecast System - Newser
Should I buy vTv Therapeutics Inc. stock before earningsFree Access to Real-Time Trade Insights - Newser
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):